VivoSim Labs, Inc. Proceeds from Related Party Debt
VivoSim Labs, Inc. (VIVS) reported Proceeds from Related Party Debt of $250.00 thousand for the 83-month period ending 2014-03-31, per its 10-K filed 2014-06-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2014-06-10
- VivoSim Labs, Inc. proceeds from related party debt for the quarter ending 2011-12-31 was $0.00.
- VivoSim Labs, Inc. proceeds from related party debt for the quarter ending 2011-09-30 was $75.00K.
- VivoSim Labs, Inc. proceeds from related party debt for fiscal 2011 was $225.00K, a 800.00% increase from fiscal 2010.
- VivoSim Labs, Inc. proceeds from related party debt for fiscal 2010 was $25.00K.
| Period end | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 6 month | Proceeds from Related Party Debt 9 month | Proceeds from Related Party Debt 12 month | Proceeds from Related Party Debt 59 month | Proceeds from Related Party Debt 62 month | Proceeds from Related Party Debt 65 month | Proceeds from Related Party Debt 68 month | Proceeds from Related Party Debt 71 month | Proceeds from Related Party Debt 74 month | Proceeds from Related Party Debt 77 month | Proceeds from Related Party Debt 80 month | Proceeds from Related Party Debt 83 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $250.00K 10-K · filed 2014-06-10 | ||||||||||||
| 2013-12-31 | $250.00K 10-Q · filed 2014-02-06 | ||||||||||||
| 2013-09-30 | $250.00K 10-Q · filed 2013-11-08 | ||||||||||||
| 2013-06-30 | $250.00K 10-Q · filed 2013-08-09 | ||||||||||||
| 2013-03-31 | $250.00K 10-KT · filed 2013-05-24 | ||||||||||||
| 2012-12-31 | $250.00K 10-K · filed 2013-03-15 | ||||||||||||
| 2012-09-30 | $250.00K 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | $250.00K 10-Q · filed 2012-08-14 | ||||||||||||
| 2012-03-31 | $250.00K 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-10 | $75.00K derived: sum of 2 quarters · filed 2014-06-10 | $225.00K 10-K · filed 2014-06-10 | ||||||||||
| 2011-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $225.00K 10-Q · filed 2012-11-14 | |||||||||||
| 2011-06-30 | $150.00K 10-Q · filed 2012-08-14 | ||||||||||||
| 2010-12-31 | $25.00K 10-KT · filed 2013-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |